Favorable News Pushes Sequenom Stock Up 57 Percent in November | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Sequenom climbed 57 percent during the month of November on a string of favorable news for the firm.

Shares of the San Diego-based molecular diagnostics developer topped gainers for the month in the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.